TrialAnnals of the rheumatic diseases2013

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Joachim Sieper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.